CHADDS FORD, Pa., Jan. 9 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals Holdings, Inc. , a market leader in pain management, advised parties interested in the Company’s previously-scheduled 5:00 conference call today to dial the following number and access code for the call:
(706) 634-1979, passcode 4156450
The 800 number for the call, provided earlier this morning, is not operating due to a network error.
A simultaneous webcast of the call for interested investors and others may be accessed by visiting http://www.endo.com. In addition, a replay of the webcast will be available until 12:00 a.m. ET on January 16, 2006. The replay can be accessed by clicking on “Events” in the Investor Relations section of the web site.
Endo Pharmaceuticals Holdings Inc. is a fully integrated specialty pharmaceutical company with market leadership in pain management products. Through its Endo Pharmaceuticals Inc. subsidiary, the company researches, develops, produces and markets a broad product offering of branded and generic pharmaceuticals, meeting the needs of healthcare professionals and consumers alike. More information, including this and past press releases of Endo Pharmaceuticals Holdings Inc., is available online at http://www.endo.com.
CONTACT: Bill Newbould Endo Pharmaceuticals (610) 558-9800
Endo Pharmaceuticals Holdings, Inc.
CONTACT: Bill Newbould of Endo Pharmaceuticals, +1-610-558-9800
Web site: http://www.endo.com/
